Markets
Alnylam Pharmaceuticals Inc (ALNY) with a beta value of 0.38 appears to be a promising investment opportunity.
On Friday, Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) was -0.28% drop from the session before settling in for the closing price of $296.75. A 52-week range
